-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
After the great success of mRNA as a new treatment model in the field of COVID-19 vaccines, where the new generation of mRNA vaccines and therapies is going has also become a concern
The company's co-founders include Dr.
However, the wider use of further promotion of RNA therapies faces a number of obstacles
The immunogenicity of mRNA and delivery vectors remains a major challenge limiting their application
Orbital's goal is to bring together and integrate existing and emerging RNA technologies and delivery mechanisms to build a unique RNA technology platform
Orbital's goal is to bring together and integrate existing and emerging RNA technologies and delivery mechanisms to build a unique RNA technology platform
The company's LNP screening platform is able to discover LNP formulations that deliver RNA to different cells and tissues
▲Beam's LNP screening platform (Image source: Beam's official website)
▲Beam's LNP screening platform (Image source: Beam's official website)In addition to providing technical support, Dr.
John Evans, CEO of Beam Therapeutics, shared how to navigate disruptive technologies at the WuXi AppTec Global Forum
John Evans, CEO of Beam Therapeutics, shared how to navigate disruptive technologies at the WuXi AppTec Global ForumOrbital's scientific founders include several pioneers in RNA research, including Professor Drew Weissman of the University of Pennsylvania who co-founded it with Dr.
Orbital's scientific founders included Professor Drew Weissman, a pioneer in RNA research, which was co-founded last year with Dr.
The innovative technology based on mRNA modifications they jointly discovered not only makes it possible to rapidly develop a COVID-19 vaccine, but is also being used to treat and prevent a range of other diseases
Professor Howard Chang of Stanford University is an expert in the field of long noncoding RNA (lnRNA), which plays an important role
"Biotechnology Company"
▲ The scientific founder of Orbital (Image source: Orbital official website)
▲ The scientific founder of Orbital (Image source: Orbital official website)Orbital's initial investments came from ARCH Venture Partners, a16z Bio + Health and Newpath Partners.
"Orbital, founded by visionary leaders and scientific pioneers, integrates a wide range of RNA technologies into one organization with the goal of developing entirely new drugs that have a profound impact on
